NO20032033D0 - Stabiliserte interferonsammensetninger - Google Patents

Stabiliserte interferonsammensetninger

Info

Publication number: NO20032033D0
Authority: NO; Norway
Prior art keywords: interferon compositions; stabilized interferon; stabilized; compositions; interferon
Prior art date: 2000-11-07

Application number

NO20032033A

Other languages

English (en)

Other versions

NO20032033L (no

NO330690B1 (no

Inventor

Sidney N Wolfe

Maninder S Hora

Original Assignee

Chiron Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-07

Filing date

2003-05-06

Publication date

2003-05-06

2003-05-06 Application filed by Chiron Corp filed Critical Chiron Corp

2003-05-06 Publication of NO20032033D0 publication Critical patent/NO20032033D0/no

2003-07-03 Publication of NO20032033L publication Critical patent/NO20032033L/no

2011-06-14 Publication of NO330690B1 publication Critical patent/NO330690B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Zoology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Gastroenterology & Hepatology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20032033A 2000-11-07 2003-05-06 Stabiliserte interferonsammensetninger, forfyllt sproyte inneholdende denne, fremgangsmate for fremstilllling samt formulering NO330690B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US24645600P	2000-11-07	2000-11-07
US25222400P	2000-11-21	2000-11-21
PCT/US2001/047514 WO2002038170A2 (en)	2000-11-07	2001-11-07	Stabilized inteferon compositions

Publications (3)

Publication Number	Publication Date
NO20032033D0 true NO20032033D0 (no)	2003-05-06
NO20032033L NO20032033L (no)	2003-07-03
NO330690B1 NO330690B1 (no)	2011-06-14

Family

ID=26937990

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20032033A NO330690B1 (no)	2000-11-07	2003-05-06	Stabiliserte interferonsammensetninger, forfyllt sproyte inneholdende denne, fremgangsmate for fremstilllling samt formulering

Country Status (16)

Country	Link
US (2)	US6994847B2 (no)
EP (1)	EP1343518B1 (no)
JP (2)	JP4129178B2 (no)
CN (1)	CN1330372C (no)
AU (2)	AU3070702A (no)
BG (1)	BG66082B1 (no)
CA (1)	CA2428144C (no)
CZ (1)	CZ20031259A3 (no)
DE (1)	DE60139339D1 (no)
ES (1)	ES2330508T3 (no)
HU (1)	HU228583B1 (no)
IL (2)	IL155788A0 (no)
NO (1)	NO330690B1 (no)
PL (1)	PL209928B1 (no)
PT (1)	PT1343518E (no)
WO (1)	WO2002038170A2 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040002451A1 (en) *	2002-06-20	2004-01-01	Bruce Kerwin	Compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing
US7119061B2 (en) *	2002-11-18	2006-10-10	Vicuron Pharmaceuticals, Inc.	Dalbavancin compositions for treatment of bacterial infections
CA2534711A1 (en) *	2003-08-01	2005-02-10	Medarex, Inc.	Combination therapies for multiple sclerosis
GB2428021A (en) *	2004-04-22	2007-01-17	Highland Ind Inc	Spacer fabric
US7276275B2 (en) *	2004-04-22	2007-10-02	Highland Industries, Inc.	Laminated spacer fabric
MX2007014148A (es)	2005-05-19	2008-01-11	Amgen Inc	Composiciones y metodos para incrementar la estabilidad de anticuerpos.
JP5139275B2 (ja) *	2005-06-21	2013-02-06	メルクパテントゲゼルシャフトミットベシュレンクテルハフツング	（ｒ）−（−）−２−［５−（４−フルオロフェニル）−３−ピリジルメチルアミノメチル］クロマンを含有する固体医薬組成物
AU2007309616B2 (en)	2006-10-20	2011-10-06	Amgen Inc.	Stable polypeptide formulations
CN101190329B (zh) *	2006-11-29	2013-03-06	信谊药厂	一种重组人p43蛋白的药物组合物及其在医药上的应用
JP2010525821A (ja)	2007-05-02	2010-07-29	アンブルックス，インコーポレイテッド	修飾ＩＦＮβポリペプチドおよびこれらの使用
JP2011195557A (ja) *	2010-02-24	2011-10-06	Kyorin Pharmaceutical Co Ltd	糖アルコールの選択方法
PE20130557A1 (es) *	2010-03-04	2013-05-19	Pfenex Inc	Metodo para producir proteinas de interferon recombinantes solubles sin desnaturalizacion
CN102585011A (zh) *	2012-02-10	2012-07-18	中国农业大学	一种犬α干扰素衍生物的制备方法与应用
SG11201703152RA (en)	2014-10-23	2017-05-30	Amgen Inc	Reducing viscosity of pharmaceutical formulations
JP7377596B2 (ja)	2017-02-22	2023-11-10	アムジエン・インコーポレーテツド	低粘度、高濃度エボロクマブ製剤及びそれらの製造方法
US10799639B2 (en) *	2017-03-03	2020-10-13	Min Wei	Syringe type medication delivery device
CN113797318B (zh) *	2021-10-26	2023-06-30	深圳科兴药业有限公司	一种干扰素组合物及其制备方法和应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4439181A (en)	1981-01-26	1984-03-27	Regents Of The University Of Minnesota	Polyol-hormone mixture for use in chronic parenteral hormone administration
JPS5821691A (ja) *	1981-07-29	1983-02-08	Mochida Pharmaceut Co Ltd	α−及びβ−インタ−フェロンの精製方法
EP0080879B1 (en)	1981-11-28	1986-10-01	Sunstar Kabushiki Kaisha	Pharmaceutical composition containing interferon in stable state
AU1234383A (en)	1982-03-17	1983-09-22	Inter-Yeda Ltd.	Interferon stabilised with polyvinyl-pyrrolidone
US5643566A (en)	1982-09-23	1997-07-01	Cetus Corporation	Formulation processes for lipophilic proteins
US4992271A (en)	1982-09-23	1991-02-12	Cetus Corporation	Formulation for lipophilic IL-2 proteins
US4462940A (en)	1982-09-23	1984-07-31	Cetus Corporation	Process for the recovery of human β-interferon-like polypeptides
US5702699A (en)	1982-09-23	1997-12-30	Cetus Corporation	Process for the recovery of lipophilic proteins
DE3484374D1 (de)	1983-08-04	1991-05-08	Green Cross Corp	Gamma-interferonzusammensetzung.
JPS6069037A (ja)	1983-09-26	1985-04-19	Sunstar Inc	エリテマト−デス治療用外用剤
JPS61500439A (ja)	1983-11-21	1986-03-13	リ−ジエンツ　オヴ　ザ　ユニヴア−シテイ−　オヴ　ミネソタ	慢性的非経口ホルモン投与用緩衝化ポリオ−ル−ホルモン混合物
US4605555A (en)	1984-09-20	1986-08-12	Sun Star Kabushiki Kaisha	Composition and method for treating keratosic disorder of skin and mucosa
US4816440A (en)	1985-09-26	1989-03-28	Cetus Corporation	Stable formulation of biologically active proteins for parenteral injection
US5183746A (en)	1986-10-27	1993-02-02	Schering Aktiengesellschaft	Formulation processes for pharmaceutical compositions of recombinant β-
CA1294215C (en)	1986-10-27	1992-01-14	Ze'ev Shaked	Pharmaceutical compositions of recombinant beta-interferon and formulation processes
US4808705A (en) *	1986-12-19	1989-02-28	Cetus Corporation	Stable formulations of ricin toxin a chain and of RTA-immunoconjugates and stabilizer screening methods therefor
US4894330A (en) *	1986-12-23	1990-01-16	Cetus Corporation	Purification of recombinant beta-interferon incorporating RP-HPLC
EP0284249A1 (en) *	1987-03-13	1988-09-28	Interferon Sciences, Inc.	Lyophilized lymphokine composition
IT1222427B (it) *	1987-07-31	1990-09-05	Sclavo Spa	Procedimento per la purificazione di interferone
US5151265A (en)	1987-11-03	1992-09-29	Genentech, Inc.	Gamma interferon formulation
US5004605A (en)	1987-12-10	1991-04-02	Cetus Corporation	Low pH pharmaceutical compositions of recombinant β-interferon
US5104651A (en)	1988-12-16	1992-04-14	Amgen Inc.	Stabilized hydrophobic protein formulations of g-csf
IL89662A (en) *	1989-03-19	1997-11-20	Interpharm Lab Ltd Kiryat Weiz	Pharmaceutical compositions comprising interferon-beta
ES2097120T3 (es)	1989-07-24	1997-04-01	Bayer Ag	Estabilizacion de proteinas altamente purificadas.
JPH05963A (ja) *	1990-04-13	1993-01-08	Toray Ind Inc	ポリペプチド類組成物
TW249202B (no)	1993-08-13	1995-06-11	Ciba Gerigy Corp
FR2710637B1 (fr)	1993-09-28	1995-12-08	Roquette Freres	Mannitol pulvérulent de friabilité modérée et son procédé de préparation.
FR2719479B1 (fr)	1994-05-04	1996-07-26	Sanofi Elf	Formulation stable lyophilisée comprenant une protéine: kit de dosage.
US5542303A (en) *	1994-05-12	1996-08-06	Neuffer; A. Erich	Dual-peak torque measuring apparatus
IT1272252B (it) *	1994-05-16	1997-06-16	Applied Research Systems	Formulazioni liquide di interferone beta
ATE299892T1 (de) *	1994-05-18	2005-08-15	Nektar Therapeutics	Methoden und zusammensetzungen für die trockenpuderarznei aus interferonen
JP2758154B2 (ja)	1995-04-06	1998-05-28	エフ・ホフマン−ラロシユアーゲー	インターフェロンを含む液体製剤
EP0875253B1 (en)	1997-05-02	2005-04-06	Seikagaku Corporation	Chondroitinase compositions
US6887462B2 (en) *	2001-04-09	2005-05-03	Chiron Corporation	HSA-free formulations of interferon-beta

2001
- 2001-11-07 JP JP2002540752A patent/JP4129178B2/ja not_active Expired - Lifetime
- 2001-11-07 US US10/010,448 patent/US6994847B2/en not_active Expired - Lifetime
- 2001-11-07 EP EP01990949A patent/EP1343518B1/en not_active Expired - Lifetime
- 2001-11-07 CN CNB018206980A patent/CN1330372C/zh not_active Expired - Lifetime
- 2001-11-07 PT PT01990949T patent/PT1343518E/pt unknown
- 2001-11-07 AU AU3070702A patent/AU3070702A/xx active Pending
- 2001-11-07 IL IL15578801A patent/IL155788A0/xx unknown
- 2001-11-07 AU AU2002230707A patent/AU2002230707B2/en not_active Expired
- 2001-11-07 ES ES01990949T patent/ES2330508T3/es not_active Expired - Lifetime
- 2001-11-07 WO PCT/US2001/047514 patent/WO2002038170A2/en active Application Filing
- 2001-11-07 PL PL366329A patent/PL209928B1/pl unknown
- 2001-11-07 DE DE60139339T patent/DE60139339D1/de not_active Expired - Lifetime
- 2001-11-07 CZ CZ20031259A patent/CZ20031259A3/cs unknown
- 2001-11-07 HU HU0301653A patent/HU228583B1/hu unknown
- 2001-11-07 CA CA2428144A patent/CA2428144C/en not_active Expired - Lifetime
2003
- 2003-05-06 NO NO20032033A patent/NO330690B1/no not_active IP Right Cessation
- 2003-05-06 IL IL155788A patent/IL155788A/en active IP Right Grant
- 2003-06-06 BG BG107887A patent/BG66082B1/bg unknown
2005
- 2005-07-22 US US11/188,257 patent/US7662369B2/en not_active Expired - Lifetime
2007
- 2007-10-25 JP JP2007278231A patent/JP2008069171A/ja active Pending

Also Published As

Publication number	Publication date
US20060008447A1 (en)	2006-01-12
EP1343518B1 (en)	2009-07-22
PT1343518E (pt)	2009-08-03
PL209928B1 (pl)	2011-11-30
BG107887A (bg)	2004-01-30
JP4129178B2 (ja)	2008-08-06
HUP0301653A2 (en)	2007-02-28
PL366329A1 (en)	2005-01-24
AU2002230707B2 (en)	2006-08-24
CN1330372C (zh)	2007-08-08
CA2428144A1 (en)	2002-05-16
US6994847B2 (en)	2006-02-07
WO2002038170A2 (en)	2002-05-16
NO20032033L (no)	2003-07-03
JP2008069171A (ja)	2008-03-27
JP2004536021A (ja)	2004-12-02
HU228583B1 (en)	2013-04-29
ES2330508T3 (es)	2009-12-11
CN1481252A (zh)	2004-03-10
US20020114782A1 (en)	2002-08-22
IL155788A0 (en)	2003-12-23
BG66082B1 (bg)	2011-03-31
DE60139339D1 (de)	2009-09-03
WO2002038170A3 (en)	2003-03-27
US7662369B2 (en)	2010-02-16
CZ20031259A3 (cs)	2004-01-14
AU3070702A (en)	2002-05-21
IL155788A (en)	2013-09-30
EP1343518A2 (en)	2003-09-17
CA2428144C (en)	2012-01-10
HUP0301653A3 (en)	2009-03-30
NO330690B1 (no)	2011-06-14

Publication	Publication Date	Title
ATE303787T1 (de)	2005-09-15	Schergelzusammensetzungen
AR028197A1 (es)	2003-04-30	Composiciones antitranspirantes
DE60142412D1 (de)	2010-07-29	Stabilisiertes interleukin 2
IS2932B (is)	2015-12-15	Fúlvestrant samsetning
FI20010780A0 (fi)	2001-04-12	Parannetut koostumukset
DE60118496D1 (de)	2006-05-18	Pulverzusammensetzung
AR028204A1 (es)	2003-04-30	Composiciones farmaceuticas electrohiladas
FI20105657L (fi)	2010-06-10	Farmaseuttisia koostumuksia
ITMI20010748A0 (it)	2001-04-06	Composizioni farmaceutiche
IS6915A (is)	2003-08-15	Lyfjablanda
BR0210619A (pt)	2006-05-23	composição
IS7081A (is)	2003-12-16	Lyfjablanda
ATE369830T1 (de)	2007-09-15	Schweisshemmende zusammensetzungen
DE60139339D1 (de)	2009-09-03	Stabilisierte interferonzusammensetzungen
ATE314049T1 (de)	2006-01-15	Schweisshemmende zusammensetzungen
NO20026123L (no)	2003-02-18	Farmasöytiske sammensetninger
NO20031095D0 (no)	2003-03-10	Farmasöytiske sammensetninger
DE60116858D1 (de)	2006-04-13	Zusammensetzung
DE60104098D1 (de)	2004-08-05	Brennstoffzusammensetzung
DE60206798D1 (de)	2006-03-02	Stabilisierte harzzusammensetzungen
NO20020524D0 (no)	2002-02-01	Stabiliserte organisk-peroksid sammensetninger
EP1313839A4 (en)	2006-01-25	IMMUNE SYSTEM INCREASING COMPOSITIONS
ITTO20020747A0 (it)	2002-08-23	Composizione
DE60107312D1 (de)	2004-12-30	Feste Zusammensetzung
ATE403414T1 (de)	2008-08-15	Shampoozusammensetzungen

Legal Events

Date	Code	Title	Description
2021-12-13	MK1K	Patent expired